BIOMAT Database Logo BIOMAT Database Logo

[Evaluation of the effectiveness of prodigiozan in acute respiratory viral infections in young infants]. 1979

A B Raĭnite-Audinene, and Iu S Uspenskiĭ, and L S Priĭmiagi, and I B Kremerman, and L Z Voloshina

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007369 Interferon Inducers Agents that promote the production and release of interferons. They include mitogens, lipopolysaccharides, and the synthetic polymers Poly A-U and Poly I-C. Viruses, bacteria, and protozoa have been also known to induce interferons. Inducers, Interferon
D011135 Polysaccharides, Bacterial Polysaccharides found in bacteria and in capsules thereof. Bacterial Polysaccharides
D011354 Prodigiozan A polysaccharide extracted from Serratia marcescens and other bacteria. It activates enzymatic activity of macrophages and stimulates phagocytic processes. Prodigiosan
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute

Related Publications

A B Raĭnite-Audinene, and Iu S Uspenskiĭ, and L S Priĭmiagi, and I B Kremerman, and L Z Voloshina
[Evaluation of the effect of prodigiozan on the course of acute respiratory viral infections].
April 1983, Pediatriia,
A B Raĭnite-Audinene, and Iu S Uspenskiĭ, and L S Priĭmiagi, and I B Kremerman, and L Z Voloshina
Viral etiology of acute respiratory infections in infants and young children.
January 1996, Roumanian archives of microbiology and immunology,
A B Raĭnite-Audinene, and Iu S Uspenskiĭ, and L S Priĭmiagi, and I B Kremerman, and L Z Voloshina
[Serum endogenous interferon indices in acute respiratory viral infections in young infants].
January 1979, Pediatriia akusherstvo i ginekologiia,
A B Raĭnite-Audinene, and Iu S Uspenskiĭ, and L S Priĭmiagi, and I B Kremerman, and L Z Voloshina
[Evaluation of interferon-genic activity and clinical effectiveness of kurantil in young children with acute respiratory viral infections].
January 1989, Pediatriia,
A B Raĭnite-Audinene, and Iu S Uspenskiĭ, and L S Priĭmiagi, and I B Kremerman, and L Z Voloshina
[Role of viral and viral-bacterial associations in the course of acute pneumonias in respiratory viral infections in young infants].
January 1980, Pediatriia,
A B Raĭnite-Audinene, and Iu S Uspenskiĭ, and L S Priĭmiagi, and I B Kremerman, and L Z Voloshina
[Evaluation of levamisole as an interferon inducer in young infants with respiratory viral infections].
September 1985, Pediatriia,
A B Raĭnite-Audinene, and Iu S Uspenskiĭ, and L S Priĭmiagi, and I B Kremerman, and L Z Voloshina
[Viral participation in acute lower respiratory infections in infants].
January 1988, Revista chilena de pediatria,
A B Raĭnite-Audinene, and Iu S Uspenskiĭ, and L S Priĭmiagi, and I B Kremerman, and L Z Voloshina
Viral Acute Respiratory Illnesses in Young Infants Increase the Risk of Respiratory Readmission.
December 2018, The Pediatric infectious disease journal,
A B Raĭnite-Audinene, and Iu S Uspenskiĭ, and L S Priĭmiagi, and I B Kremerman, and L Z Voloshina
[Prevention of acute respiratory viral infections in infants attending nurseries].
May 1980, Meditsinskaia sestra,
A B Raĭnite-Audinene, and Iu S Uspenskiĭ, and L S Priĭmiagi, and I B Kremerman, and L Z Voloshina
[Diagnosis of mixed acute respiratory viral infections in young children].
June 1968, Pediatriia,
Copied contents to your clipboard!